Genmab — Maj 2025

Helge_LarsenPI-redaktør

Investeringspodcasten 274: Status på de danske aktier https://proinvestor.com/boards/126364

Helge_LarsenPI-redaktør

Genmab: 14.33

E_L

EHA 25 embargoed until Thursday, June 12

E_L

actually, we can see them now already

E_L

maybe i should post the link for the more
lazy people https://library.ehaweb.org/eha/#!*search=epcoritamab*browseby=8*listing=0*sortby=1

E_L

EHA25 - EPCORE NHL-5 - Fixed-duration epcor + pola-R-CHP with follow-up of 16.1 mos in pts with newly diagnosed : ORR was 100% with 97% achieving a CR

E_L

EHA25 - EPCORE NHL-2 -Epcor + R-ICE demonstrated high CR rates in pts with R/R DLBCL eligible for ASCT, most of whom were high risk, having progressed <12 mo of 1L tx. ORR was 87%; 20 pts (65%) had a CR and 7 (23%) a partial response (PR

Solsen

Til sammenligning til EPCORE NHL-2: Background:
First-line (1L) standard of care (SOC) for diffuse large B-cell lymphoma (DLBCL) is rituximab plus C, H, vincristine, and P (R-CHOP), and it continues to evolve with pola-R-CHP showing higher complete response rates (CRR) of 78% and longer progression-free survival (PFS) than R-CHOP (Tilly 2022)